JP3596622B2 - External preparation for preventing skin aging - Google Patents

External preparation for preventing skin aging Download PDF

Info

Publication number
JP3596622B2
JP3596622B2 JP30353093A JP30353093A JP3596622B2 JP 3596622 B2 JP3596622 B2 JP 3596622B2 JP 30353093 A JP30353093 A JP 30353093A JP 30353093 A JP30353093 A JP 30353093A JP 3596622 B2 JP3596622 B2 JP 3596622B2
Authority
JP
Japan
Prior art keywords
skin
trihydroxybenzoic acid
oxygen species
ester
external preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP30353093A
Other languages
Japanese (ja)
Other versions
JPH07133218A (en
Inventor
仁 正木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP30353093A priority Critical patent/JP3596622B2/en
Publication of JPH07133218A publication Critical patent/JPH07133218A/en
Application granted granted Critical
Publication of JP3596622B2 publication Critical patent/JP3596622B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【0001】
【産業上の利用分野】
本発明は、新規な活性酸素種消去剤である3,4,5−トリヒドロキシ安息香酸の糖エステルを配合して成る、安全性及び安定性に優れる皮膚の老化防止用外用剤に関する。
【0002】
【従来の技術】
近年、太陽光の皮膚に対する影響が研究され、太陽光により皮膚内に生じる一重項酸素,ヒドロキシラジカル,スーパーオキシドといった活性酸素種が、表皮ケラチノサイトや真皮の線維芽細胞を攻撃し、これら細胞を死に至らしめ、その結果、皮膚の老化や種々の皮膚疾患を引き起こすことが明らかになってきた。それにつれて、このような活性酸素種を消去する物質のスクリーニングも行われ、ビタミンE群化合物やビタミンC、動植物由来のスーパーオキシドディスムターゼ様作用物質、さらにはスーパーオキシドディスムターゼ自体を皮膚外用剤に配合する試みがなされている。
【0003】
しかし、従来用いられていたビタミンE,ビタミンCのような活性酸素種消去剤は、細胞に対する親和性が低く、かなり多量に配合しなければ効果が生じなかった。動植物由来のスーパーオキシドディスムターゼ様作用物質も、天然起源であり、一定した作用を有するものを得るのが難しく、安定性も低く品質管理上の問題があった。さらに、スーパーオキシドディスムターゼ自体の配合も、酵素活性の安定化や皮膚感作性等の面で問題があった。
【0004】
【発明が解決しようとする課題】
本発明は、細胞親和性が高く、少量の配合で有効な活性酸素種消去作用を示し、且つ皮膚外用剤中で安定で、しかも安全性の高い活性酸素種消去剤を配合し、活性酸素種に起因する皮膚の老化防止や疾患を防止し得る皮膚外用剤を提供するものである。
【0005】
【課題を解決するための手段】
上記の課題を解決するため、細胞親和性の高い活性酸素種消去剤の検討を行ったところ、3,4,5−トリヒドロキシ安息香酸を糖エステルとすることにより、本発明の目的が達成されることを見い出した。糖としては、エステル化のしやすさや糖エステルの水溶性、感作性の出現等を考慮すると、単糖類又は二糖類〜三糖類くらいのオリゴ糖が好ましい。本発明の目的には、エリスロース,トレオース等のテトロース類、アラビノース,キシロース,リボース等のペントース類、ガラクトース,グルコース,マンノース,プシコース,フルクトース等のヘキソース類、N−アセチルガラクトサミン,N−アセチルグルコサミン,マンノサミン等のアミノ糖類、マルトース,ラクトース,ショ糖,セロビオース等の二糖類、セロトリオース等の三糖類などが好適な例として挙げることができる。
【0006】
3,4,5−トリヒドロキシ安息香酸の糖エステルは、たとえば3,4,5−トリヒドロキシ安息香酸をエステル化し、これと糖とを水酸化ナトリウム等のアルカリ触媒存在下にて反応させ、エステル交換反応等により合成することができる。なお、副生成物のアルコールを系から除去すると、反応を効率よく進ませることができる。
【0007】
3,4,5−トリヒドロキシ安息香酸の糖エステルは、エタノール等のアルコールに溶解したり、基剤中に分散したりして皮膚外用剤に配合できる。皮膚外用剤は液剤,乳剤,クリーム,軟膏など種々の形態を採ることができる。また、化粧水や乳液,皮膚用クリーム等、化粧料としても提供することができる。配合量は、皮膚外用剤中の有効濃度を考慮して、0.01〜10重量%が適当である。
【0008】
【作用】
3,4,5−トリヒドロキシ安息香酸の糖エステルの活性酸素種による細胞傷害防御作用は、ヒト線維芽細胞に活性酸素種を曝露し、その際の細胞生存率を指標として評価できる。培養したヒト線維芽細胞に、3,4,5−トリヒドロキシ安息香酸のグルコースエステル,ガラクトースエステル,ラクトースエステルをそれぞれ作用させた後、洗浄し、ヒポキサンチン−キサンチンオキシダーゼ系にて活性酸素種(スーパーオキシド及びヒドロキシラジカル)を曝露した。曝露後の細胞生存率はMTT還元法により測定した。比較のため、3,4,5−トリヒドロキシ安息香酸で同様に細胞を処理した場合についても測定した。
【0009】
MTT還元法は、細胞のミトコンドリア内に存在する脱水素酵素が基質に作用して生じる還元型ニコチンアミドアデニンジヌクレオチド(NADH)により、系に添加したMTT(2−(4,5−dimethyl−2−thiazolyl)−3,5−diphenyltetrazolium bromide)のテトラゾリウム環が開環することを利用する測定法である。テトラゾリウム環の開環により、青色のフォルマザンが生成するので、これを560nmにおける吸光度により測定して、細胞生存率を求める。
【0010】
その結果、図1に示すように、良好な細胞親和性を有する3,4,5−トリヒドロキシ安息香酸のグルコースエステル,ガラクトースエステル,ラクトースエステルの各糖エステルで処理した場合には、70〜80%の良好な細胞生存率を示した。これに対し、糖エステル化していない3,4,5−トリヒドロキシ安息香酸自体で処理した場合は、細胞親和性が低いため、細胞生存率は40%弱と低かった。
【0011】
従って、3,4,5−トリヒドロキシ安息香酸の糖エステルは、細胞膜に対し良好な親和性を示し、細胞膜表面において活性酸素種を効率良く消去することができる。その結果、非常に低濃度で活性酸素種による細胞傷害を防止し、活性酸素種の細胞傷害作用による皮膚の老化症状や疾患を有効に防止することができる。
【0012】
【実施例】
さらに、本発明について実施例により詳細に説明する。本発明の実施例として、3,4,5−トリヒドロキシ安息香酸のブドウ糖エステルを配合した乳液(実施例1)、3,4,5−トリヒドロキシ安息香酸のN−アセチルグルコサミンエステルを配合した皮膚用クリーム(実施例2)、3,4,5−トリヒドロキシ安息香酸のショ糖エステルを配合した乳剤性軟膏(実施例3)の処方を、それぞれ表1,表2,表3に示した。
【0013】
表1中、(1)〜(5)の油相成分を混合,溶解して均一とし、75℃に加熱する。一方、(8)を(7)に溶解して(6),(10),(13)の水相成分とともに75℃に加熱する。次いで、上記の水相成分に油相成分を添加して予備乳化し、これに(9)を加えた後ホモミキサーにて均一に乳化する。その後冷却し、(11)を加えてpHを調整し、50℃にて(12)を添加し、均一に混合する。
【表1】

Figure 0003596622
【0014】
表2中、(1)〜(7)の油相成分を混合,溶解して均一とし、75℃に加熱する。一方、(9)を(8)に溶解して(10),(12)とともに75℃に加熱する。次いで、上記水相成分に油相成分を添加して予備乳化した後、ホモミキサーにて均一に乳化する。その後冷却し、50℃にて(11)を添加,混合する。
【表2】
Figure 0003596622
【0015】
表3中、(1)〜(4)の油相成分を混合,溶解して均一とし、75℃に加熱する。一方、(8)を(7)に溶解して(5),(6),(9)とともに75℃に加熱する。次いで上記水相成分を油相成分に添加して乳化し、冷却する。
【表3】
Figure 0003596622
【0016】
本発明の実施例について、実際に使用試験を行った。この際、各実施例で用いた3,4,5−トリヒドロキシ安息香酸の糖エステルの替わりに、3,4,5−トリヒドロキシ安息香酸を用いたものを比較例1,2及び3とした。使用試験は、日常戸外で作業する40〜60才代のパネラー20名を1群とし、実施例及び比較例をブラインドにて各群に5月〜7月の3カ月間使用させ、使用後の皮膚のしわ,きめ,はり、及び肌荒れの改善状況を観察し、評価した。皮膚のしわ,きめ及び肌荒れの改善状況については写真撮影による外観観察により、皮膚のはりについては皮膚弾性の測定により評価し、しわについては「軽減」,「やや軽減」,「変化なし」,「増加」、きめ及びはりについては「良好」,「やや良好」,「変化なし」,「悪化」又は「低下」、肌荒れについては「改善」,「やや改善」,「変化なし」,「悪化」の各4段階で評価した。結果は、各評価を得たパネラー数にて表4に示した。
【表4】
Figure 0003596622
【0017】
表4より明らかなように、各実施例使用群ではしわの増加を認めたパネラーはなく、90%以上のパネラーにおいてしわの軽減を認めた。きめ及びはりについてはいずれも使用開始前より良好となっており、肌荒れの改善も全パネラーにおいて認められた。これに対して比較例使用群では、しわについては2〜3例において軽減傾向が認められたのみで、40〜55%のパネラーにおいてはしわの増加が認められた。きめ及びはりについても、使用開始前より良好となったパネラーは少なく、きめについては15〜20%、はりについては30〜35%のパネラーにおいて悪化又は低下したと評価された。肌荒れについてもほとんどのパネラーにおいて改善が認められなかった。
【0018】
本使用試験において各パネラーは、紫外線曝露量の多い5月〜7月にほぼ毎日戸外で作業をしており、表4の結果は、本発明の実施例が紫外線曝露により生じる活性酸素種に起因する皮膚の老化や肌荒れを有効に予防,改善し得ることを示唆するものである。
【0019】
【発明の効果】
以上詳述したように、本発明により、太陽光により生じる活性酸素種を有効に除去して、これらに起因する皮膚の老化,疾患を良好に防止し得る皮膚外用剤を提供することができた。
【図面の簡単な説明】
【図1】本発明で活性酸素種消去剤として用いる3,4,5−トリヒドロキシ安息香酸の糖エステルと、3,4,5−トリヒドロキシ安息香酸の細胞傷害防御作用を示す図である。
【符号の説明】
1 3,4,5−トリヒドロキシ安息香酸のグルコースエステル
2 3,4,5−トリヒドロキシ安息香酸のガラクトースエステル
3 3,4,5−トリヒドロキシ安息香酸のラクトースエステル
4 3,4,5−トリヒドロキシ安息香酸[0001]
[Industrial applications]
The present invention relates to an external preparation for preventing skin aging, which is excellent in safety and stability, comprising a sugar ester of 3,4,5-trihydroxybenzoic acid, which is a novel active oxygen species-eliminating agent.
[0002]
[Prior art]
In recent years, the effects of sunlight on the skin have been studied, and reactive oxygen species such as singlet oxygen, hydroxyl radicals, and superoxide generated in the skin by sunlight attack epidermal keratinocytes and dermal fibroblasts and kill these cells. As a result, it has been revealed that it causes skin aging and various skin diseases. Along with this, screening for substances that eliminate such reactive oxygen species is also carried out, and vitamin E group compounds, vitamin C, superoxide dismutase-like substances derived from animals and plants, and superoxide dismutase itself are added to a skin external preparation. Attempts have been made.
[0003]
However, conventionally used reactive oxygen species scavengers such as vitamin E and vitamin C have low affinity for cells, and have no effect unless they are added in a considerably large amount. Superoxide dismutase-like substances derived from animals and plants are also of natural origin, and it is difficult to obtain a substance having a constant action, and the stability is low and there is a problem in quality control. Furthermore, blending of superoxide dismutase itself has problems in terms of stabilization of enzyme activity and skin sensitization.
[0004]
[Problems to be solved by the invention]
The present invention has a high cell affinity, exhibits an effective reactive oxygen species scavenging action in a small amount, and incorporates a stable and highly safe active oxygen species scavenger in a skin external preparation, It is intended to provide a skin external preparation capable of preventing skin aging and diseases caused by the above.
[0005]
[Means for Solving the Problems]
In order to solve the above problems, a study was made on a reactive oxygen species scavenger having a high cell affinity, and the object of the present invention was achieved by converting 3,4,5-trihydroxybenzoic acid into a sugar ester. I found something. As the saccharide, an oligosaccharide such as a monosaccharide or a disaccharide to a trisaccharide is preferable in consideration of ease of esterification, water solubility of the sugar ester, appearance of sensitization, and the like. For the purpose of the present invention, tetroses such as erythrose and threose, pentoses such as arabinose, xylose and ribose, hexoses such as galactose, glucose, mannose, psicose and fructose, N-acetylgalactosamine, N-acetylglucosamine, Preferred examples include amino sugars such as mannosamine, disaccharides such as maltose, lactose, sucrose, and cellobiose, and trisaccharides such as cellotriose.
[0006]
The sugar ester of 3,4,5-trihydroxybenzoic acid is obtained, for example, by esterifying 3,4,5-trihydroxybenzoic acid, reacting this with sugar in the presence of an alkali catalyst such as sodium hydroxide, and the like. It can be synthesized by an exchange reaction or the like. When the alcohol by-product is removed from the system, the reaction can proceed efficiently.
[0007]
The sugar ester of 3,4,5-trihydroxybenzoic acid can be dissolved in an alcohol such as ethanol or dispersed in a base and blended into an external preparation for skin. The external preparation for skin can take various forms such as a liquid preparation, an emulsion, a cream and an ointment. In addition, it can be provided as a cosmetic such as a lotion, an emulsion, and a cream for skin. The amount is suitably 0.01 to 10% by weight in consideration of the effective concentration in the external preparation for skin.
[0008]
[Action]
The cytotoxic protective action of reactive sugar species of 3,4,5-trihydroxybenzoic acid sugar ester by reactive oxygen species can be evaluated using human fibroblasts exposed to reactive oxygen species and cell viability at that time as an index. Glucose ester, galactose ester and lactose ester of 3,4,5-trihydroxybenzoic acid were allowed to act on the cultured human fibroblasts, and then washed, and reactive oxygen species (super-oxygen) were added using a hypoxanthine-xanthine oxidase system. Oxides and hydroxy radicals). The cell viability after the exposure was measured by the MTT reduction method. For comparison, a measurement was also made for the case where the cells were similarly treated with 3,4,5-trihydroxybenzoic acid.
[0009]
In the MTT reduction method, a reduced nicotinamide adenine dinucleotide (NADH) generated by a dehydrogenase present in the mitochondria of a cell acting on a substrate is used to add MTT (2- (4,5-dimethyl-2 ) to a system. -Thiazolyl) -3,5-diphenyltetrazolium bromide). Since blue formazan is generated by the opening of the tetrazolium ring, this is measured by the absorbance at 560 nm to determine the cell viability.
[0010]
As a result, as shown in FIG. 1, when treated with glucose ester, galactose ester and lactose ester of 3,4,5-trihydroxybenzoic acid having good cell affinity, 70-80%. % Cell viability. On the other hand, when the cells were treated with 3,4,5-trihydroxybenzoic acid itself, which had not been subjected to sugar esterification, the cell viability was as low as slightly less than 40% due to low cell affinity.
[0011]
Therefore, the sugar ester of 3,4,5-trihydroxybenzoic acid has a good affinity for the cell membrane, and can efficiently eliminate active oxygen species on the cell membrane surface. As a result, cell damage due to reactive oxygen species can be prevented at a very low concentration, and aging symptoms and diseases of the skin due to the cytotoxic action of reactive oxygen species can be effectively prevented.
[0012]
【Example】
Further, the present invention will be described in detail with reference to examples. Examples of the present invention include an emulsion containing a glucose ester of 3,4,5-trihydroxybenzoic acid (Example 1) and a skin containing an N-acetylglucosamine ester of 3,4,5-trihydroxybenzoic acid. Tables 1, 2 and 3 show the formulations of the cream for use (Example 2) and the emulsion ointment containing the sucrose ester of 3,4,5-trihydroxybenzoic acid (Example 3), respectively.
[0013]
In Table 1, the oil phase components (1) to (5) are mixed and dissolved to make uniform, and heated to 75 ° C. On the other hand, (8) is dissolved in (7) and heated to 75 ° C. together with the aqueous phase components (6), (10) and (13). Next, the oil phase component is added to the aqueous phase component to perform preliminary emulsification, and (9) is added thereto, followed by uniform emulsification using a homomixer. Thereafter, the mixture is cooled, pH is adjusted by adding (11), (12) is added at 50 ° C., and the mixture is uniformly mixed.
[Table 1]
Figure 0003596622
[0014]
In Table 2, the oil phase components (1) to (7) are mixed and dissolved to make uniform, and heated to 75 ° C. On the other hand, (9) is dissolved in (8) and heated to 75 ° C. together with (10) and (12). Next, the oil phase component is added to the water phase component and pre-emulsified, and then homogenized uniformly with a homomixer. Thereafter, the mixture is cooled, (11) is added and mixed at 50 ° C.
[Table 2]
Figure 0003596622
[0015]
In Table 3, the oil phase components (1) to (4) are mixed and dissolved to make uniform, and heated to 75 ° C. On the other hand, (8) is dissolved in (7) and heated to 75 ° C. together with (5), (6) and (9). Next, the aqueous phase component is added to the oil phase component, emulsified, and cooled.
[Table 3]
Figure 0003596622
[0016]
An actual use test was performed on the examples of the present invention. In this case, Comparative Examples 1, 2, and 3 were obtained using 3,4,5-trihydroxybenzoic acid instead of the sugar ester of 3,4,5-trihydroxybenzoic acid used in each Example. . In the use test, 20 panelists in their 40s and 60s who work outdoors outdoors were grouped as one group, and the examples and comparative examples were blindly used by each group for three months from May to July. The state of improvement of skin wrinkles, texture, abrasion, and rough skin was observed and evaluated. Improvement of skin wrinkles, texture and rough skin was evaluated by observing the appearance by photography, and skin swelling was evaluated by measurement of skin elasticity. Wrinkles were evaluated as “reduced”, “slightly reduced”, “no change”, “ “Increase”, “Good”, “Slightly good”, “No change”, “Deterioration” or “Decrease” for texture and beam, “Improvement”, “Slightly improvement”, “No change”, “Deterioration” for rough skin Of each of the four grades. The results are shown in Table 4 by the number of panelists who obtained each evaluation.
[Table 4]
Figure 0003596622
[0017]
As is evident from Table 4, none of the panelists using each example showed an increase in wrinkles, and the reduction of wrinkles was observed in 90% or more of the panelists. Both the texture and the beam were better than before the start of use, and the improvement of rough skin was also observed in all panelists. On the other hand, in the group using the comparative example, wrinkles were only reduced in a few cases of wrinkles, and wrinkles increased in 40 to 55% of panelists. Regarding the texture and the beam, the number of panelists who became better than before the start of use was small, and it was evaluated that 15-20% of the texture and 30-35% of the beam deteriorated or decreased. No improvement was observed in skin roughness on most panelists.
[0018]
In this use test, each panelist worked outdoors almost every day from May to July, when the amount of UV exposure was high, and the results in Table 4 show that the examples of the present invention were caused by reactive oxygen species generated by UV exposure. This suggests that skin aging and rough skin can be effectively prevented and improved.
[0019]
【The invention's effect】
INDUSTRIAL APPLICABILITY As described above in detail, the present invention can provide a skin external preparation capable of effectively removing active oxygen species generated by sunlight and successfully preventing skin aging and diseases caused by these. .
[Brief description of the drawings]
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a diagram showing cytotoxic protective effects of 3,4,5-trihydroxybenzoic acid sugar ester and 3,4,5-trihydroxybenzoic acid used as active oxygen species scavengers in the present invention.
[Explanation of symbols]
1 Glucose ester of 3,4,5-trihydroxybenzoic acid 2 Galactose ester of 3,4,5-trihydroxybenzoic acid 3 Lactose ester of 3,4,5-trihydroxybenzoic acid 4 3,4,5-Tri Hydroxybenzoic acid

Claims (1)

3,4,5-トリヒドロキシ安息香酸の糖エステル(グルコースエステルを除く)を配合して成る、活性酸素種による皮膚の老化を防止ししわ、きめ、はり、肌荒れを改善する皮膚老化防止用外用剤。External use for preventing skin aging due to reactive oxygen species that prevents aging of skin due to reactive oxygen species and improves skin wrinkles, texture, abrasion, and skin roughness, formulated with 3,4,5-trihydroxybenzoic acid sugar ester (excluding glucose ester) Agent.
JP30353093A 1993-11-08 1993-11-08 External preparation for preventing skin aging Expired - Fee Related JP3596622B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP30353093A JP3596622B2 (en) 1993-11-08 1993-11-08 External preparation for preventing skin aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30353093A JP3596622B2 (en) 1993-11-08 1993-11-08 External preparation for preventing skin aging

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003290988A Division JP2004002468A (en) 2003-08-11 2003-08-11 Eliminating agent of active-oxygen species

Publications (2)

Publication Number Publication Date
JPH07133218A JPH07133218A (en) 1995-05-23
JP3596622B2 true JP3596622B2 (en) 2004-12-02

Family

ID=17922104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP30353093A Expired - Fee Related JP3596622B2 (en) 1993-11-08 1993-11-08 External preparation for preventing skin aging

Country Status (1)

Country Link
JP (1) JP3596622B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737410B1 (en) * 1995-07-31 1997-09-12 Oreal USE OF BENZOIC ACID DERIVATIVES TO PROMOTE SKIN DEQUAMATION OR STIMULATE THE EPIDERMAL RENEWAL PROCESS
EP1340486A1 (en) * 2002-03-01 2003-09-03 Cognis France S.A. Use of sugar esters
JP6222888B2 (en) * 2011-12-22 2017-11-01 ホーユー株式会社 Hair and skin external preparation composition and non-therapeutic cosmetic method
JP6151542B2 (en) * 2013-03-19 2017-06-21 上野製薬株式会社 New salicylic acid derivatives
CN104829659B (en) * 2015-04-13 2017-10-24 江苏康缘药业股份有限公司 A kind of compound and its preparation and application

Also Published As

Publication number Publication date
JPH07133218A (en) 1995-05-23

Similar Documents

Publication Publication Date Title
US8309116B2 (en) Personal care and cosmetics compositions comprising biologically-based mono and di esters
JPH04507089A (en) Stable ascorbic acid composition
JP2001342110A (en) Skin care preparation
CN109414398A (en) Antioxidant composition for skin
DE102009045798A1 (en) Cosmetic agent, useful for lightening e.g. skin, comprises peroxidase and substrate for hydrogen peroxide producing enzyme in a first container, and hydrogen peroxide producing enzyme and substrate for the peroxidase in a second container
JP2929304B2 (en) Skin whitening preparation for external use
CN108451893B (en) Toning lotion with long-acting moisturizing effect and preparation method thereof
CN115192472B (en) Whitening essence containing ionic liquid humanized type III collagen and preparation method thereof
JP3489082B2 (en) Cosmetic use of compositions having anti-erythema activity and corresponding compositions
JP3596622B2 (en) External preparation for preventing skin aging
CN110538083B (en) Mild foam amino acid cleansing cream and preparation method thereof
JPH06256137A (en) Beautifying dermatic external preparation
JPH07133216A (en) External agent for preventing aging of skin
JP2008044891A (en) Compounding agent for composition for external use
JP3645318B2 (en) Anti-aging skin external preparation
US6258366B1 (en) Method of preparing a cosmetic product intending to protect the skin against attacks resulting from pollution of the ambient air
JP4039567B2 (en) Aqueous cosmetics
JP2004002468A (en) Eliminating agent of active-oxygen species
CN113749964B (en) Ultraviolet filtering agent compound, preparation method and application thereof, and sunscreen product
JPH1059839A (en) Preparation for external use for skin
JP3380261B2 (en) Cosmetics
JP5290562B2 (en) Anti-wrinkle agent and skin preparation for preventing wrinkle formation
CN111821219A (en) Composition with moisturizing effect and application thereof
JPH0672823A (en) Cosmetic containing alkenylsuccinic acid ester of sugar
JP2000109419A (en) Composition for moisturizing and composition for external use for skin containing the same

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040519

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040714

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040901

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040901

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070917

Year of fee payment: 3

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D05

LAPS Cancellation because of no payment of annual fees